Genitourinary Syndrome of Menopause
Overview
Affiliations
Introduced in 2014, genitourinary syndrome of menopause (GSM) describes a variety of unpleasant genital, sexual and urinary symptoms that can either be isolated or coexisting and are not related to other medical conditions. GSM is a chronic and progressive condition that requires early recognition and appropriate management to preserve urogenital health. Despite the importance of early detection and treatment, the condition is consistently underdiagnosed and undertreated. Herein, we emphasize how to diagnose GSM in postmenopausal, hypoestrogenic, and hypoandrogenic women and summarize evidence-based treatments focusing on prescription treatments and adjunctive therapies.
Oyardi P, Ural U J Turk Ger Gynecol Assoc. 2025; 26(1):15-19.
PMID: 40077950 PMC: 11905206. DOI: 10.4274/jtgga.galenos.2024.2024-5-6.
Impact of Endocrine Disruptors on the Genitourinary Tract.
Caneparo C, Carignan L, Lonina E, Goulet S, Pellerin F, Chabaud S J Xenobiot. 2024; 14(4):1849-1888.
PMID: 39728407 PMC: 11676856. DOI: 10.3390/jox14040099.
Development and Bioavailability Assessment of an Estriol-Containing Vaginal Hydrogel.
Takacs P, Kozma B, Ratonyi D, Kozma B, Attila K, Fenyvesi F Gels. 2024; 10(12).
PMID: 39727581 PMC: 11675891. DOI: 10.3390/gels10120823.
Wang Y, Jiesisibieke Z, Yang Y, Wang B, Hsiung M, Tung T JMIR Public Health Surveill. 2024; 10:e60136.
PMID: 39727265 PMC: 11693784. DOI: 10.2196/60136.
Brazilian Guideline on Menopausal Cardiovascular Health - 2024.
Oliveira G, Almeida M, Arcelus C, Espindola L, Rivera M, Silva-Filho A Rev Bras Ginecol Obstet. 2024; 46.
PMID: 39530071 PMC: 11554338. DOI: 10.61622/rbgo/2024rbgo100.